⌘+K

Pulse Explore Clubs Researchers Journals

Home Clubs Explore

April 22, 2014Current Opinion in Lipidology

Hypobetalipoproteinemia and abetalipoproteinemia

View Full Paper

Ask AI

Bookmark

Share

Design

Review

Authors

FWFrancine K. WeltyGeneral / Preventive / Lipids

Discussion

Loading...

Member takes

Implication

Guides LDL-lowering drug targets from genetic insights; leaves open prospective clinical validation.

Key Points

Key points are not available for this paper at this time.

Cite This Study

Francine K. Welty (2014) studied this question.

synapsesocial.com/papers/69eedea8a84321e0ae63c4d9 https://doi.org/10.1097/mol.0000000000000072

Topics

Coronary artery disease

View Full Paper

Ask AI

Bookmark

Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

1Lipolysis exposes unreactive endogenous apolipoprotein E-3 in human and rat plasma very low density lipoprotein.1991 · 60 citations
2Effect of liver fat on insulin clearance2007 · 202 citations
3Human apolipoprotein B-100 heparin-binding sites.1987 · 193 citations
4A Novel APOB Mutation Identified by Exome Sequencing Cosegregates With Steatosis, Liver Cancer, and Hypocholesterolemia2013 · 81 citations
5Fatty liver in familial hypobetalipoproteinemia: triglyceride assembly into VLDL particles is affected by the extent of hepatic steatosis2003 · 143 citations